Gemina Labs Provides Technical Development Update for Initial Diagnostic Test and Reports Filing of New IP

VANCOUVER, BC / ACCESSWIRE / March 31, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to provide recent development updates for its initial diagnostic test targeting the COVID-19 virus. Since achieving the …